Novavax (NVAX) Operating Income Growth (5y) (2015 - 2026)
Novavax (NVAX) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Novavax | 1.24 Bn | 448.12 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.60% |
| Dec 31, 2025 | 15.75% |
| Sep 30, 2025 | 1.70% |
| Jun 30, 2025 | 51.33% |
| Mar 31, 2025 | 89.62% |
| Dec 31, 2024 | -35.49% |
| Sep 30, 2024 | -54.99% |
| Jun 30, 2024 | 44.91% |
| Mar 31, 2024 | -29.20% |
| Dec 31, 2023 | -31.60% |
| Sep 30, 2023 | -24.56% |
| Jun 30, 2023 | 27.13% |
| Mar 31, 2023 | -48.36% |
| Dec 31, 2022 | -38.54% |
| Sep 30, 2022 | -25.03% |
| Jun 30, 2022 | -63.39% |
| Mar 31, 2022 | 48.11% |
| Sep 30, 2021 | -7.39% |
| Jun 30, 2021 | -35.22% |
| Mar 31, 2021 | -22.62% |